To further explore mechanisms mediating haptoglobin and hemopexin inhibition of microvascular stasis and provide a basis for replacement therapy in SCD patients, we examined the role of HO-1 in haptoglobin and hemopexin-mediated protection. The gene discussed is HPX; the disease is Schnyder corneal dystrophy.